Pacific Biosciences Of California | PACB - Capital Ordinaire





Capital Ordinaire Changement Date
Agilent USD 281.97M 252K 2026-06
Bruker USD 152.35M 130K 2026-06
Danaher USD 703.4M 500K 2026-09
General Electric Aerospace USD 1.03B 4.21M 2026-09
Illumina USD 151.3M 607K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quidel USD 68.1M 200K 2026-03
Revvity USD 111.63M 174K 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Standard Biotools USD 390.14M 3.76M 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Waters USD 98.19M 20K 2026-06